Peter H. Krammer

Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis.

P. Krammer, K. Elkon, T. Lehman, 1995, Arthritis and rheumatism.

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.

P. Krammer, K. Elkon, M. Chao, 1999, The Journal of clinical investigation.

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

M. Peter, S. Fesik, J. Puck, 1999, Proceedings of the National Academy of Sciences of the United States of America.